GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Future Medicine Co Ltd (XKRX:341170) » Definitions » Deferred Policy Acquisition Costs

Future Medicine Co (XKRX:341170) Deferred Policy Acquisition Costs


View and export this data going back to 2022. Start your Free Trial

What is Future Medicine Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Future Medicine Co Business Description

Traded in Other Exchanges
N/A
Address
54 changup-ro, 616, 2 Techno Valley Enterprise Growth Center, Gyeonggi-do, Siheung-dong, LH Pangyo-je, Seongnam-si, KOR, 13449
Future Medicine Co Ltd is a drug development company. It engages in the development of new drug candidates for anti-inflammatory/anti-fibrosis of non-alcoholic hepatitis (NASH) drugs, oral glaucoma treatments, and chronic kidney disease treatments, as well as targeted and Immuno cancer drugs.